Squarepoint’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-3,404
| Closed | -$105K | – | 2642 |
|
|
2021
Q3 | $105K | Sell |
3,404
-2,871
| -46% | -$88.6K | ﹤0.01% | 1991 |
|
|
2021
Q2 | $204K | Sell |
6,275
-3,031
| -33% | -$98.5K | ﹤0.01% | 2218 |
|
|
2021
Q1 | $352K | Buy |
+9,306
| New | +$352K | ﹤0.01% | 1770 |
|
|
2020
Q4 | – | Sell |
-3,861
| Closed | -$125K | – | 2661 |
|
|
2020
Q3 | $125K | Sell |
3,861
-955
| -20% | -$30.9K | ﹤0.01% | 2075 |
|
|
2020
Q2 | $212K | Buy |
4,816
+1,988
| +70% | +$87.5K | ﹤0.01% | 1731 |
|
|
2020
Q1 | $93K | Buy |
+2,828
| New | +$93K | ﹤0.01% | 1646 |
|
|
2019
Q3 | – | Sell |
-3,296
| Closed | -$182K | – | 2353 |
|
|
2019
Q2 | $182K | Buy |
3,296
+1,309
| +66% | +$72.3K | ﹤0.01% | 2052 |
|
|
2019
Q1 | $121K | Buy |
+1,987
| New | +$121K | ﹤0.01% | 1966 |
|
|
2018
Q4 | – | Sell |
-2,973
| Closed | -$240K | – | 2046 |
|
|
2018
Q3 | $240K | Sell |
2,973
-1,915
| -39% | -$155K | ﹤0.01% | 1657 |
|
|
2018
Q2 | $428K | Buy |
+4,888
| New | +$428K | 0.01% | 1240 |
|